InvestorsHub Logo
Followers 27
Posts 3554
Boards Moderated 0
Alias Born 11/25/2003

Re: None

Wednesday, 06/04/2014 10:02:42 PM

Wednesday, June 04, 2014 10:02:42 PM

Post# of 724
Teva has been on an acquisition spree of late. The company acquired NuPathe Inc. in Feb 2014, which added to its portfolio the only FDA-approved migraine patch, Zecuity, for the treatment of acute migraine (with or without aura) in adults. The LBR-101 development program coupled with Zecuity will boost Teva's pain portfolio.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PATH News